A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 demonstrated potent virus-neutralizing ability by targeting a difficult-to-reach ...

Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, ...

A groundbreaking deal will make a new HIV prevention drug affordable in over 100 low-income countries, potentially advancing ...

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...

Researchers at Case Western Reserve University identified for the first time how HIV enters a dormant state in infected cells that allows the virus to “hide” from the immune system and current ...

Wes Sundquist wasn't trying to become one of TIME's 100 most influential people in the world. He wasn't shooting for Science ...

Gilead has agreed to provide the drug at cost and to share its intellectual property with generic manufacturers who can ...

Uganda is set to introduce a new long-acting HIV prevention drug, Lenacapavir, in 2026 under a United States-funded ...